Oral Peanut Immunotherapy for Peanut Allergic Patients
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a study to determine if peanut oral immunotherapy (OIT) would desensitize or tolerize
peanut allergic patients to peanuts in order prevent peanut allergic reactions.